首頁 > 市場調查報告書 > 製藥

處方藥疼痛

局部鎮痛藥市場規模、佔有率和成長分析（按治療分類、劑型、性別、年齡層、類型、配銷通路和地區分類）－2026-2033年行業預測

市場調查報告書

商品編碼

1898488

局部鎮痛藥市場規模、佔有率和成長分析（按治療分類、劑型、性別、年齡層、類型、配銷通路和地區分類）－2026-2033年行業預測

Topical Pain Relief Market Size, Share, and Growth Analysis, By Therapeutic Classes (Non-opioids, Opioids), By Formulation (Cream, Gel), By Gender, By Age Group, By Type, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球局部止痛藥市場規模將達到 120.2 億美元，到 2025 年將達到 129 億美元，到 2033 年將達到 226.6 億美元，預測期（2026-2033 年）的複合年成長率為 7.3%。

關節炎盛行率的不斷上升顯著推動了全球外用止痛藥市場的收入成長。此外，人口老化加劇以及運動員的高需求也促進了這個市場的發展。該市場的特點在於對細分市場、發展趨勢、促進因素和競爭動態的全面分析。糖尿病神經病變和癌症相關疼痛等發生率的上升也進一步擴大了市場機會。與口服藥物相比，外用解決方案的副作用較少，因此更受青睞。然而，潛在的皮膚刺激和難聞的氣味等挑戰可能會阻礙市場成長。同時，線上平台的興起和新興市場的成長為市場擴張提供了充滿希望的途徑，凸顯了塑造外用止痛藥市場的挑戰與機會之間複雜的平衡關係。

全球局部止痛藥市場促進因素

慢性疼痛疾病（包括關節炎、肌肉骨骼疾病和神經病變疼痛）的日益普遍，是推動局部止痛藥需求成長的主要因素。越來越多的人尋求有效、局部的疼痛管理方案，既方便又能精準緩解疼痛。這一趨勢反映了消費者偏好的轉變，他們希望找到一種能夠輕鬆應用於特定疼痛部位的治療方法，從而提高整體止痛效果。隨著人們對這些疾病的認知不斷提高，局部止痛藥市場持續擴張，以滿足人們對快速起效、便捷止痛方案的不斷成長的需求。

限制全球局部止痛藥市場的因素

由於缺乏全面的臨床證據支持其療效和安全性，全球外用止痛藥市場面臨嚴峻挑戰。這種證據的匱乏會削弱消費者的信任，阻礙產品的普及，因為潛在使用者在缺乏嚴謹研究的實證支持時，可能不願意依賴這些產品。因此，外用止痛藥療效和安全性的不確定性限制了消費者和醫療保健提供者對其的接受度，並嚴重阻礙因素了該細分市場的成長和擴張。彌合這一差距對於建立信任和促進產品普及至關重要。

全球局部鎮痛藥市場趨勢

全球局部止痛藥市場正呈現出明顯的趨勢，即擴大採用天然草本成分，這反映出消費者對健康保健類產品的偏好日益成長。隨著消費者對合成替代品的認知度下降，他們對利用植物成分（以其止痛和抗發炎功效而聞名）的配方需求不斷增加。這種轉變源自於消費者對更安全、化學成分更少的產品的偏好，迫使製造商不斷創新並拓展產品線。因此，市場正在朝著更重視透明度、原料來源和永續性的方向發展，這與更廣泛的消費者健康趨勢相符。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Johnson & Johnson（United States）
GlaxoSmithKline plc（United Kingdom）
Novartis AG（Switzerland）
Pfizer Inc.（United States）
Reckitt Benckiser Group plc（United Kingdom）
Sun Pharmaceutical Industries Ltd.（India）
Endo International plc（Ireland）
Teva Pharmaceutical Industries Ltd.（Israel）
Sanofi SA（France）
Mylan NV（now part of Viatris Inc.）（United States）
AdvaCare Pharma（United States）
Topical Biomedics Inc.（United States）

結論與建議

簡介目錄

Product Code: SQMIG35I2258

Global Topical Pain Relief Market size was valued at USD 12.02 Billion in 2024 and is poised to grow from USD 12.9 Billion in 2025 to USD 22.66 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The growing prevalence of arthritis significantly drives revenue growth in the global topical pain relief market. Additionally, the increasing elderly population and high demand among athletes contribute to this expansion. The market is characterized by a thorough analysis of segments, trends, drivers, and competitive dynamics. Factors such as rising cases of diabetic neuropathy and cancer-related pain further enhance market opportunities. The shift toward topical solutions is favored due to their reduced side effects compared to oral medications. Nonetheless, challenges like potential skin irritation and unpleasant odors can hinder growth. In contrast, the rise of online platforms and emerging markets present exciting avenues for expansion, highlighting the intricate balance of challenges and opportunities shaping the topical pain relief landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Topical Pain Relief market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Topical Pain Relief Market Segments Analysis

Global Topical Pain Relief Market is segmented by Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel and region. Based on Therapeutic Classes, the market is segmented into Non-opioids and Opioids. Based on Formulation, the market is segmented into Cream, Gel, Spray, Patch and Others. Based on Gender, the market is segmented into Women and Men. Based on Age Group, the market is segmented into Adults (18-64 Years) and Geriatric (65 Years and Above). Based on Type, the market is segmented into Prescription Pain Relief and Over the Counter (OTC) Pain Relief. Based on Distribution Channel, the market is segmented into Pharmacy and Drug Stores, Retail Stores and Online Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Topical Pain Relief Market

The growing prevalence of chronic pain conditions, including arthritis, musculoskeletal disorders, and neuropathic pain, significantly fuels the demand for topical pain relief options. Individuals are increasingly looking for effective localized pain management solutions that provide both convenience and focused alleviation. This trend reflects a shift in consumer preferences towards therapies that can be easily applied to specific areas of discomfort, enhancing the overall efficacy of pain relief strategies. As awareness of these conditions rises, the market for topical pain relief products continues to expand, catering to the evolving needs of those seeking immediate and accessible solutions for pain alleviation.

Restraints in the Global Topical Pain Relief Market

The global market for topical pain relief products faces a significant challenge stemming from the lack of comprehensive clinical evidence that substantiates their efficacy and safety. This deficiency can undermine consumer confidence and impede widespread adoption, as potential users may be hesitant to rely on these products without substantiated proof from rigorous studies. Consequently, the uncertainty regarding the effectiveness and safety profiles of topical pain relief options can limit their acceptance among both consumers and healthcare providers, presenting a notable restraint in the growth and expansion of this market segment. Addressing this gap is crucial for fostering trust and enhancing product uptake.

Market Trends of the Global Topical Pain Relief Market

The Global Topical Pain Relief market is experiencing a notable trend towards the incorporation of natural and herbal ingredients, reflecting a growing consumer preference for products that emphasize health and wellness. As awareness of synthetic alternatives diminishes, individuals are gravitating towards formulations that harness the power of botanicals, known for their analgesic and anti-inflammatory properties. This shift is driven by a desire for safer, less chemically laden options, prompting manufacturers to innovate and expand their product lines. Consequently, the market is evolving, with an increasing emphasis on transparency, ingredient sourcing, and sustainability, aligning with broader consumer wellness trends.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Customer And Buying Criteria Analysis
Regulatory Analysis

Global Topical Pain Relief Market Size by Therapeutic Classes & CAGR (2026-2033)

Market Overview
Non-opioids
- Nonsteroidal anti-inflammatory drug (NSAIDS)
- Methyl salicylates
- Capsaicin
- Lidocaine
- Other non-opioids
Opioids
- Buprenorphine
- Fentanyl

Global Topical Pain Relief Market Size by Formulation & CAGR (2026-2033)

Market Overview
Cream
Gel
Spray
Patch
Others

Global Topical Pain Relief Market Size by Gender & CAGR (2026-2033)

Market Overview
Women
Men

Global Topical Pain Relief Market Size by Age Group & CAGR (2026-2033)

Market Overview
Adults (18-64 Years)
Geriatric (65 Years and Above)

Global Topical Pain Relief Market Size by Type & CAGR (2026-2033)

Market Overview
Prescription Pain Relief
Over the Counter (OTC) Pain Relief

Global Topical Pain Relief Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Pharmacy and Drug Stores
Retail Stores
Online Stores

Global Topical Pain Relief Market Size & CAGR (2026-2033)

North America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
- US
- Canada
Europe (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reckitt Benckiser Group plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endo International plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (now part of Viatris Inc.) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AdvaCare Pharma (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Topical Biomedics Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments